Facebook

All categories

  • All categories
  • Flow Cytometry Antibodies
  • Immunoassays
  • Cell Isolation and Identification
  • Cell Health and Metabolism Assay Kits
  • Cell Culture
  • Antibodies and Reagents
  • Proteins and Peptides
Please enter the item number/product keyword!
Keyword cannot be empty !
INSERT SYMBOLS:
  • α
  • β
  • γ
  • δ
  • ε
  • ζ
  • η
  • θ
  • κ
  • μ
  • ω
  • σ
  • τ
  • λ
  • Ⅰ
  • Ⅱ
  • Ⅲ
  • Ⅳ
  • Ⅴ
  • Ⅵ
  • Ⅶ
  • Ⅷ
  • Ⅸ
  • Ⅹ
  • Ⅺ
  • Ⅻ
  • ⅩⅢ
  • ⅩⅢ
  • ⅩⅣ
  • ⅩⅤ
  • ⅩⅦ
  • ⅩⅧ
  • UP ↑
All Size Price Qty
100μL $ 320.00
- +
50μL $ 211.00
- +
Add to cart

For research use only.

Verified Samples Verified Samples in WB: NIH-3T3
Dilution WB 1:1000-1:5000,  IF 1:200-1:1000,  IP 1:50-1:200,  ELISA 1:5000-1:20000
Isotype Rabbit IgG
Host Rabbit
Reactivity Human,  Mouse,  Rat,  Drosophila
Applications WB,  IF,  IP,  ELISA
Clonality Monoclonal;Recombinant
Immunogen A synthetic peptide corresponding to residues around (Thr308) of Human Phospho-Akt (pan)
Abbre Akt (Thr308)
Synonyms AKT,  AKT 1,  AKT serine/threonine kinase,  AKT serine/threonine kinase 1,  AKT1,  Akt1/2/3,  AKT1_HUMAN,  CWS,  CWS6,  MGC,  MGC99656,  PKB,  PKB-ALPHA,  PRKBA,  Protein kinase B,  Protein Kinase B Alpha,  Proto-oncogene c-Akt,  RAC,  RAC Alpha,  RAC-ALPHA,  RAC-alpha serine/threonine-protein kinase,  RAC-PK-alpha
Swissprot
Calculated MW 60 kDa
Observed MW 60 kDa

Western blotting is a method for detecting a certain protein in a complex sample based on the specific binding of antigen and antibody. Different proteins can be divided into bands based on different mobility rates. The mobility is affected by many factors, which may cause the observed band size to be inconsistent with the expected size. The common factors include:

1. Post-translational modifications: For example, modifications such as glycosylation, phosphorylation, methylation, and acetylation will increase the molecular weight of the protein.

2. Splicing variants: Different expression patterns of various mRNA splicing bodies may produce proteins of different sizes.

3. Post-translational cleavage: Many proteins are first synthesized into precursor proteins and then cleaved to form active forms, such as COL1A1.

4. Relative charge: the composition of amino acids (the proportion of charged amino acids and uncharged amino acids).

5. Formation of multimers: For example, in protein dimer, strong interactions between proteins can cause the bands to be larger. However, the use of reducing conditions can usually avoid the formation of multimers.

If a protein in a sample has different modified forms at the same time, multiple bands may be detected on the membrane.

Cellular Localization Cytoplasm, Nucleus, Cell membrane
Tissue Specificity Expressed in prostate cancer and levels increase from the normal to the malignant state (at protein level). Expressed in all human cell types so far analyzed. The Tyr-176 phosphorylated form shows a significant increase in expression in breast cancers during the progressive stages i.e. normal to hyperplasia (ADH), ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC) and lymph node metastatic (LNMM) stages.
Concentration 0.20 mg/mL
Buffer PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.
Purification Method Protein A affinity purification
Research Areas Signal Transduction,  Epigenetics and Nuclear Signaling,  Cancer,  Metabolism,  Neuroscience
Clone C170953
Conjugation Unconjugated
Storage Store at -20℃ Valid for 12 months. Avoid freeze/thaw cycles.
Shipping Ice bag
background AKT1 encodes one of the three closely related members of the AKT (also known as protein kinase B, PKB) serine/threonine kinase family, comprising AKT1 (PKBα), AKT2 (PKBβ), and AKT3 (PKBγ). These isoforms share a conserved protein structure consisting of an N-terminal pleckstrin homology (PH) domain, a central serine/threonine kinase domain, and a C-terminal regulatory domain. AKT kinases are key downstream effectors of the phosphoinositide 3-kinase (PI3K) signaling pathway, which is activated by various extracellular signals, including insulin and growth factors such as epidermal growth factor (EGF), platelet-derived growth factor (PDGF), and insulin-like growth factor 1 (IGF-1). Upon PI3K activation, phosphatidylinositol 3,4,5-trisphosphate (PIP3) is generated from phosphatidylinositol 4,5-bisphosphate (PIP2), promoting the recruitment of AKT to the plasma membrane. Full activation of AKT1 requires phosphorylation at Thr308 and Ser473. AKT activity is negatively regulated by protein phosphatases that dephosphorylate AKT or reduce PIP3 levels. Once activated, AKT regulates diverse cellular processes, including cell proliferation, survival, metabolism, apoptosis, and angiogenesis. It promotes cell survival by phosphorylating and inhibiting components of the apoptotic machinery, while also regulating protein synthesis and cell growth through the mechanistic target of rapamycin (mTOR) signaling pathway. AKT additionally participates in the regulation of glucose uptake and glycogen synthesis, linking growth factor and insulin signaling to cellular metabolism. Dysregulation of the PI3K/AKT/mTOR pathway is frequently associated with tumor development and progression. Aberrant AKT signaling, including gene amplification, overexpression, and activating mutations, has been implicated in various cancers. In particular, AKT1 mutations are associated with several malignancies and overgrowth disorders, including breast, colorectal, and ovarian cancers, as well as Proteus syndrome and Cowden syndrome 6. Although AKT1, AKT2, and AKT3 share overlapping signaling functions, they also exhibit distinct biological roles. AKT1 is broadly involved in cell growth, proliferation, and survival; AKT2 plays a prominent role in insulin signaling and glucose metabolism and is also implicated in cancer progression; while AKT3 is predominantly expressed in the brain and contributes to brain development and function. These differences highlight the importance of investigating individual AKT isoforms in physiological and pathological processes.
Product Recommendations for Literature Synchronization

Note: Data for this module come from published literature that cites this product, displaying other products used together in the same research paper.

  • IF:{{item.impact}}

    Journal:{{item.journal}} ({{item.year}})

    DOI:{{item.doi}}

    Reactivity:{{item.species}}

    Sample Type:{{item.sample_type}}

  • Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}}

No files available. Please enter the correct identification code in the search area to query the relevant documents.

empty
Product Information
Title Status Valid until Action
{{v.文件名}} {{v.status_str}} {{v.timestamp_str}} Download /

*Note:Please download the relevant files within the validity period. After expiration, file preview and download will not be available on the page.

确定